搜索临床试验以:Japanese, GSK1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy
总计36486个结果
-
Taisho Pharmaceutical R&D Inc.完全的
-
Novartis Pharmaceuticals完全的Mild Moderate | or Severe Renal Impairment德国
-
Astellas Pharma Global Development, Inc.FibroGen完全的
-
Astellas Pharma Global Development, Inc.完全的
-
Janssen Research & Development, LLC完全的
-
Chiesi Farmaceutici S.p.A.完全的
-
Chiesi Farmaceutici S.p.A.终止
-
Drugs for Neglected DiseasesBayer; Bill and Melinda Gates Foundation完全的
-
Janssen Research & Development, LLC完全的
-
Boehringer IngelheimEli Lilly and Company完全的
-
GlaxoSmithKlineNucleus Network Ltd完全的
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey Clinic完全的
-
GlaxoSmithKlineHammersmith Medicines Research; Covance Harrogate完全的
-
GlaxoSmithKlineMedicines for Malaria Venture完全的
-
GlaxoSmithKline完全的
-
Janssen Research & Development, LLC终止
-
Janssen Research & Development, LLC完全的
-
Chiesi Farmaceutici S.p.A.完全的
-
GlaxoSmithKline完全的
-
GlaxoSmithKline终止
-
GlaxoSmithKline终止
-
GlaxoSmithKline终止
-
GlaxoSmithKline完全的
-
GlaxoSmithKline完全的